Health Discovery Corporation
OTC Bulletin Board : HDVY

November 16, 2005 09:34 ET

Health Discovery Corporation Announces Sale of Biomarker Signature for AIDS

SAVANNAH, Ga.--(CCNMatthews - Nov 16, 2005) -

University of Miami to Acquire HDC's Recently Discovered AIDS Biomarker Signature and Agrees to Continuing Royalty Payments for Any Future Commercial Sales related to Biomarkers

Health Discovery Corporation announced today that the University of Miami will acquire full ownership of the recent AIDS Biomarker Signature discovered by the scientists at Health Discovery Corporation using the company's patent-protected Fractal Genomic Modeling (FGM) Technology. The University of Miami agreed to an upfront cash payment and continuing royalty payments for any future commercial sales related to this new discovery. Financial terms of the acquisition were not disclosed.

Savannah-based Health Discovery Corporation (OTCBB: HDVY) is uniquely positioned in the field of pattern recognition. Through its broad patent portfolio and the efforts of its recognized scientific team, HDC is focused on commercializing its intellectual property in genomic and proteomic biomarker discovery, medical imaging, diagnostics, and pharmaceutical advancements in personalized medicine. The company's patent-protected technology also has significant application in non-medical fields that require manipulation and analysis of large, complex datasets such as insurance, financial markets, Internet search & spam, and homeland security.

This news release contains "forward-looking statements" within the meaning of Section 27a of the Securities Acts of 1933 and Section 21E of the Securities Exchange Act of 1934. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove correct.

Contact Information